PIK3CA and neoplasm: Some PIK3CA composite mutations have already been proved to increase cell proliferation, tumor growth but also PI3K inhibitor sensitivity in human breast epithelial cell lines, but to the best of our knowledge, it has not been linked to being the product of AID activity40,41.